norethindrone and norethindrone enanthate

norethindrone has been researched along with norethindrone enanthate in 175 studies

Research

Studies (175)

TimeframeStudies, this research(%)All Research%
pre-199076 (43.43)18.7374
1990's31 (17.71)18.2507
2000's34 (19.43)29.6817
2010's27 (15.43)24.3611
2020's7 (4.00)2.80

Authors

AuthorsStudies
Cullins, VE1
Fotherby, K; Griffin, M; McEwan, JA; Trayner, I1
Crona, N; Enk, L; Landgren, BM; Lindberg, UB; Silfverstolpe, G1
Albornoz, H; Díaz, M; Kesserü, E; Socolsky, R1
Aydinlik, S; Etchepareborda, JJ; Kaufmann, J; von Kesserü, E1
Griffin, M; McEwan, JA1
Ge, JL; Liu, XH; Lu, FY; Mao, SM; Sang, GW; Shao, QX1
Koetsawang, S1
Shaaban, MM1
Abdel-Razik, M; al-Azzony, M; al-Kholy, G; Fahmy, K; Saad, S; Shaaraway, M; Wagdi, A1
Sapire, KE1
Meng, YX; Virutamasen, P1
Garza-Flores, J; Hall, PE; Perez-Palacios, G1
Jiang, HY; Lu, FY; Meng, YX1
Chen, AJ; Fotherby, K; Jiang, HY; Lu, FY; Meng, YX; Shao, QX; Shen, KY; Sun, DL; Yang, H; Zhang, MY1
Bretin, H; Herschkorn, P; Lasselain, J; Thebaud-Mony, A1
Artini, P; Coukos, G; Genazzani, AD; Genazzani, AR; Lattesa, AM; Nappi, C; Petraglia, F; Silferi, M; Volpe, A1
Abdel-Al, S; Chalaby, S; el-Seginy, A; Gamal-Eldin, H; Nor-Eldin, M1
Bhowmik, T; Mukherjea, M3
Alba, VM; Alvarado, G; Bassol, S; Cravioto, MC; Garza-Flores, J; Hernandez, L; Perez-Palacios, G; Recio, R; Rivera, R1
Kaunitz, AM1
Arolkar, SG; Chadha, UC; Chitlange, S; Gokral, JS; Hazari, KT; Joshi, JV; Shah, RS1
Keller, PJ1
Odlind, V1
Fraser, IS2
Liu, XH; Sang, GW1
Chinvanthannond, P; Samransamruajkit, S1
el-Faras, A; el-Sibai, FA; Ismail, AA; Rocca, M; Toppozada, M1
Rabe, T; Runnebaum, B1
Amatayakul, K; Petpoo, W; Ratanawananukul, N; Suriyanon, V; Tanthayaphinant, O; Tovanabutra, S1
Bergamaschi, M; Facchinetti, F; Genazzani, AD; Genazzani, AR; Petraglia, F; Volpe, A1
Aly, MY; Fathalla, MF; Salah, M; Salem, HT; Shaaban, MM; Thabet, AI1
Born, HJ; Hörster-Poschmann, P; Kuhl, H; Sandow, J; Stoll, W; Taubert, HD1
Shen, KY1
Anderson, J; Cravioto, MC; del Real Mora, O; Díaz Sánchez, V; Garza-Flores, J; Landeros, J; Lichtenberg, R; Pérez-Palacios, G; Rodríguez, V1
Cardenas, S; Cravioto, MC; Diaz-Sanchez, V; Garza-Flores, J; Perez-Palacios, G; Rodríguez, V1
Griffin, M; Heaton, DA; McEwan, JA1
Dhanapas, S; Leepipatpaiboon, S; Virutamasen, P1
Chang, CY; Peng, XR; Zou, JC1
Majumdar, S; Nagpaul, JP; Singh, R1
Born, HJ; Kuhl, H; Schneider, M; Schneider, R; Taubert, HD1
Ahmed, N; Akhter, H; Busca, B; Chowdhury, SM; Holck, SE; Jabeen, S; Khatoon, J; Malakar, M; Rahman, S; Rahman, SS1
Baweja, R; Bhattacharya, SK; Choudhury, SD; Datey, S; Krishna, U; Kumar, S; Manuel, M; Mehta, S; Phillips, FS; Saxena, NC1
Diethelm, P; Holck, SE; Kazi, A1
Chaudhuri, C; Dutta, SK; Mukherjea, M1
Blair, M; Elder, MG; Fotherby, K; Hamawi, A; Howard, G; Trayner, I1
Ajabor, LN; Ezimokhai, M; Izilien, MI; Jackson, M1
Benagiano, G; Primiero, FM1
Birke, LI; Holzhausen, C; Murphy, S1
Elder, MG1
Correu Azcona, S; Velasco Murillo, V1
Banerjee, SK; Baweja, R; Bhatt, RV; Chatterjee, A; Choudhury, SD; Coyaji, B; Engineer, AD; Gogoi, MP; Hingorani, V1
Lähteenmäki, P; Lähteenmäki, PL; Toivonen, J1
Abdel-Rahman, H; El-Sahwi, SY; Saleh, FM; Sallam, HN; Souka, AR; Toppozada, HK1
Cruickshank, J; McMaster, M; Weir, RJ; Wilson, ES1
Babu, S; Prema, K; Ramalakshmi, BA1
Jahan, FA; Khan, AR; Swenson, I1
Fraser, IS; Weisberg, E1
Fernández-Aparicio, MA; Medina, M; Pérez-Palacios, G; Ulloa-Aguirre, A; Zacarías-Villareal, J1
Sang, GW; Zhao, XJ1
Chávez, B; Escobar, N; Larrea, F; Lince, M; Pérez, AE; Pérez-Palacios, G; Vilchis, F1
Chaudhuri, C; Mukherjea, M1
Johannisson, E; Landgren, BM; Zalányi, S1
Etchegoyen, G; Galván, E; Landeros, J; Pérez-Palacios, G; Wolpert, E1
Elder, MG; Fotherby, K; Muggeridge, J; Towobola, O1
Correu Azcona, S; García López, E; Ortiz López, J; Velasco Murillo, V1
Abaza, MS; Kandeel, KM; Nayel, SA1
Bye, PG; Elder, M; Fotherby, K; Hamawi, A; Howard, G1
Elder, MG; Fotherby, K; Howard, G; Muggeridge, J; Yong-En, S1
Andino, N1
Fotherby, K1
Elder, MG; Fotherby, K; Hamawi, A; Howard, G; Trayner, I1
Sivin, I1
Blair, M; Bye, PG; Chen, JK; Elder, MG; Fotherby, K; Howard, G; Muggeridge, J1
Fotherby, K; Koetsawang, S1
Chowdhury, SR; Srivastava, UK1
De Cecco, L; Rainer, E; Rossato, P1
Mendiratta, R; Srivastava, UK1
Back, DJ; Breckenridge, AM; Chapman, CR; Crawford, FE; Olsen, KA; Orme, ML; Rowe, PH1
Bye, PG; Elder, M; Fotherby, K; Howard, G; Sang, GW1
Born, HJ; Franz, I; Kuhl, H; Schneider, M; Taubert, HD1
Srivastava, UK1
Nair, KM; Prasad, KV; Prema, K; Rao, BS; Sivakumar, B1
Akhter, N; Choudhury, SA1
Channiyom, K; Dusitsin, N; Leepipatpaiboon, S; Vaivanijkul, B; Virutamasen, P; Werawatgoompa, S1
Fotherby, K; Khan, FS1
Aydinlik, S; Etchepareborda, JJ; von Kesseru, E1
Günzel, P; Seibert, B1
Giwa-Osagie, OF1
Chinvanthananond, P1
d'Arcangues, C1
Affandi, B; Hadisaputra, W; Rogers, PA; Siregar, B; Wonodirekso, S1
Nair, KM; Ravinder, P; Shatrugna, V; Sivakumar, B1
Altamirano, L; Canales, JR; De Aguilar, MA; De Fung, RC; Gonzalez, JD; Grillo, AE; Leon, DA; Pozuelos, JL; Ramirez, L; Rigionni, R; Salgado, JS; Sanchez, Jdel C; Torres, L; Vallecillos, G; Zambrano, EJ; Zea, C1
Berk, M; De Jager, M; Hofmeyr, GJ; Lawrie, TA; Paiker, J; Viljoen, E1
Dakin, L; Rowlands, SC1
Diebäcker, J; Kamischke, A; Nieschlag, E1
Affandi, B; Barasila, AC; Damayanti, L; Rogers, PA; Siregar, B; Wonodirekso, S1
Kamischke, A; Nieschlag, E; Plöger, D; Venherm, S; von Eckardstein, S1
Gray, A; McFadyen, L; Smit, J; Zuma, K1
Beksinska, ME; Rees, HV; Smit, J1
Heuermann, T; Kamischke, A; Krüger, K; Nieschlag, E; Rübig, A; Schellschmidt, I; von Eckardstein, S1
Eickenberg, U; Kemper, S; Lemmnitz, G; Nieschlag, E; Rolf, C1
McFadyen, L; Preston-Whyte, E; Smit, J; Zuma, K1
Beksinska, ME; Rees, HV1
DOUGLAS, M; LORAINE, JA; STRONG, JA1
Beksinska, ME; Farley, TM; Guidozzi, F; Kleinschmidt, I; Rees, HV; Smit, JA1
Bassol, S; Canto de Cetina, TE; Cetina Canto, JA; Luna, MO1
Adil, SN; Afsar, NA; Barakzai, Q1
Africander, D; Hapgood, JP; Koubovec, D; Louw, A1
Bertaccini, A; Bremner, WJ; Costantino, A; D'Emidio, L; Ernst, M; Kirsch, B; Martorana, G; Meriggiola, MC; Morselli Labate, AM; Pelusi, G; Rudolph, I; Saad, F1
Beksinska, ME; Farley, TM; Kleinschmidt, I; Mbatha, F; Smit, JA1
Junaidi, A; Kamischke, A; Luetjens, CM; Nieschlag, E; Simoni, M; Wistuba, J; Yeung, CH1
Erren, M; Kamischke, A; Nieschlag, E; Simoni, M; Zitzmann, M1
Affandi, B1
Araújo, FF; Barbieri, M; Bortolotti de Mello Jacobucci, MS; Guazzelli, CA; Moron, AF1
Hoffman, M; Morroni, C; Moss, M; Myer, L1
Bremner, WJ; Cerpolini, S; Martorana, G; Mbizvo, MT; Meriggiola, MC; Pelusi, G; Vogelsong, KM1
Beksinska, M; Draper, BH; Hapgood, J; Hoffman, M; Morroni, C; Smit, J; Van der Merwe, L1
Bahamondes, L; dos Santos Fernandes, AM; Juliato, CT; Simões, JA; Sobreira-Lima, B; Villarreal, M1
Denny, L; Kuhn, L; Myer, L; Wright, TC1
Beksinska, ME; Farley, TM; Kleinschmidt, I; Smit, JA3
Delany, S; Dinat, N; Kleinschmidt, I; McIntyre, JA; Nkala, B; Rees, H; Smith, D1
Constant, D; Cooper, D; Hoffman, M; Kalla, AA; Micklesfield, L; Rosenberg, L; Zhang, Y1
Atabey, N; Dogan, E; Kizildag, S; Koyuncuoglu, M; Posaci, C; Saatli, B; Ulukus, EC1
Dennis, CL; Herxheimer, A; Ross, LE1
González, EA; Molina, RC; Molina, TG; Montero, AV; Oyarzún, PG; Sandoval, JZ1
Beksinska, ME; Farley, TM; Kleinschmidt, I; Rees, HV; Smit, JA1
Atashili, J; Delany, S; Kleinschmidt, I; Miller, WC; Pettifor, A; Rees, H1
Beksinska, ME; Farley, TM; Kleinschmidt, I; Milford, C; Smit, JA1
Balogun, OR; Raji, HO1
Weisberg, E1
Cerpolini, S; Costantino, A; Meriggiola, MC; Pasquali, R; Pelusi, C; Pelusi, G1
Nieschlag, E1
Ahmed, K; Chen, PL; Friedland, B; Gehret-Plagianos, M; Kwok, C; Lahteenmaki, P; Morrison, CS; Patel, S; Ramjee, G; Skoler-Karpoff, S; van de Wijgert, J1
Friderichs-Gromoll, S; Luetjens, CM; Nieschlag, E; Sandhowe-Klaverkamp, R; Semjonow, A; Simoni, M; Wistuba, J; Zitzmann, M1
Gallo, MF; Grimes, DA; Halpern, V; Lopez, LM; Nanda, K; Schulz, KF1
Damm, OS; Ehmcke, J; Luetjens, CM; Nieschlag, E; Redmann, K; Sandhowe-Klaverkamp, R; Schlatt, S; Simoni, M; Steinhoff, A; Wistuba, J1
d'Arcangues, C; Gallo, MF; Grimes, DA; Lopez, LM; Schulz, KF1
Hallett, T; McCoy, SI; Padian, N; Ralph, LJ1
Curtis, KM; Polis, CB1
Abass, MM; Abdul-Hadi, RA; Aiyenigba, BO; Chabikuli, ON; Hamelmann, C; Ibrahim, MD; Ladipo, OA; Odafe, S; Oseni, LO1
Avenant, C; Govender, Y; Hapgood, JP; Ray, RM; Tomasicchio, M1
Cooney, R; Hayward, P1
Blanchard, K; Chipato, T; Harper, CC; Nhemachena, T; Ramjee, G1
Curtis, KM; Hannaford, P; Phillips, SJ; Polis, CB; Raymond, E; Steyn, PS; Turner, AN; Westreich, DJ1
Baeten, JM; Brown, J; Chen, PL; Crook, AM; Delany-Moretlwe, S; Francis, SC; Friedland, BA; Hayes, RJ; Heffron, R; Kapiga, S; Karim, QA; Karpoff, S; Kaul, R; Kwok, C; Low, N; McClelland, RS; McCormack, S; McGrath, N; Morrison, CS; Myer, L; Rees, H; Stalter, R; Van Damme, L; van de Wijgert, JH; van der Straten, A; Watson-Jones, D1
Baeten, JM; Balkus, JE; Bunge, K; Chirenje, ZM; Gomez, K; Hillier, SL; Marrazzo, JM; Nair, G; Noguchi, LM; Palanee-Phillips, T; Parikh, UM; Piper, JM; Ramjee, G; Richardson, BA; Selepe, P; van der Straten, A; Watts, DH1
Abdellati, S; Agot, K; Ahmed, K; Cohen, M; Crucitti, T; Deese, J; Masson, L; Miller, W; Morrison, C; Van Damme, L; Wang, M1
Callahan, R; Halpern, V; Nanda, K; Yacobson, I1
Gollub, EL; Jones, HE; Ralph, LJ1
Bergel, E; Hofmeyr, GJ; Lawrie, TA; Singata-Madliki, M; Temmerman, M1
Anderson, RA; Behre, HM; Callahan, MM; Colvard, DS; Festin, MP; Habib, NA; Handelsman, DJ; Lestari, SW; Linton, KA; McLachlan, RI; Meriggiola, MC; Misro, MM; Noe, G; Vogelsong, KM; Wu, FC; Zitzmann, M1
Baeten, JM; Balkus, JE; Brown, ER; Chappell, C; Harkoo, I; Jeenarain, N; Kabwigu, S; Kintu, K; Kiweewa, FM; Marzinke, M; Naidoo, L; Nair, G; Nakabiito, C; Palanee-Phillips, T; Reddy, K; Siva, S; Soto-Torres, L1
Bahall, M; Santlal, M1
Achilles, SL; Austin, MN; Chirenje, ZM; Hillier, SL; Meyn, LA; Mhlanga, F1
Balle, C; Bekker, LG; Bosinger, SE; Galmieldien, H; Gill, K; Happel, AU; Jaspan, HB; Jaumdally, SZ; Konstantinus, IN; Masson, L; Myer, L; Passmore, JS; Pidwell, T; Sinkala, M; Tanko, RF1
Achilles, SL; Chirenje, ZM; Hillier, SL; Maramba, A; Matubu, A; Mbizvo, M; Meyn, LA; Mhlanga, F; Stoner, KA1
Aceves, KM; Cherpes, TL; Gabriel, JM; Hatfield, AM; Kaur, B; Kwiek, JJ; Quispe Calla, NE; Torres, AR; Trout, W; Vicetti Miguel, RD1
Balle, C; Barnabas, SL; Bekker, LG; Esra, R; Gamieldien, H; Gill, K; Happel, AU; Jaspan, HB; Jaumdally, SZ; Konstantinus, IN; Lennard, K; Lesosky, M; Maseko, V; Myer, L; Passmore, JS; Pidwell, T1
Balle, C; Barnabas, SL; Bekker, LG; Bosinger, SE; Brodie, E; Esra, R; Gamieldien, H; Gill, K; Happel, AU; Havyarimana, E; Jaspan, HB; Jaumdally, SZ; Karaoz, U; Konstantinus, IN; Lennard, K; Maseko, V; Moodie, Z; Myer, L; Passmore, JS; Pidwell, T1
Achilles, SL; Chirenje, ZM; Hillier, SL; Maramba, A; Matubu, AT; Mbizvo, M; Meyn, LA; Mhlanga, F; Stoner, KA1
Baeten, JM; Balle, C; Bekker, LG; Brown, BP; Bunjun, R; Dabee, S; Feng, C; Gill, K; Happel, AU; Heffron, R; Jaspan, HB; Jaumdally, SZ; Konstantinus, IN; Nair, G; Onono, M; Palanee-Phillips, T; Passmore, JS; Tanko, RF1

Reviews

23 review(s) available for norethindrone and norethindrone enanthate

ArticleYear
Injectable and implantable contraceptives.
    Current opinion in obstetrics & gynecology, 1992, Volume: 4, Issue:4

    Topics: Capsules; Contraceptive Agents, Female; Drug Implants; Humans; Injections; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Microspheres; Norethindrone

1992
The injectable contraceptive: present and future trends.
    Annals of the New York Academy of Sciences, 1991, Volume: 626

    Topics: Contraception; Contraceptive Agents, Female; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone

1991
Long-acting hormonal contraceptives for women.
    The Journal of steroid biochemistry and molecular biology, 1991, Volume: 40, Issue:4-6

    Topics: Aniline Compounds; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Levonorgestrel; Norethindrone; Norethindrone Acetate; Ovulation

1991
Injectable contraception.
    Clinical obstetrics and gynecology, 1989, Volume: 32, Issue:2

    Topics: Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone

1989
[Hormonal contraception using depot preparations].
    Therapeutische Umschau. Revue therapeutique, 1986, Volume: 43, Issue:5

    Topics: Abnormalities, Drug-Induced; Blood Coagulation; Carbohydrate Metabolism; Cardiovascular Diseases; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Infant, Newborn; Levonorgestrel; Liver; Medroxyprogesterone; Medroxyprogesterone Acetate; Neoplasms; Norethindrone; Norgestrel; Pregnancy; Risk

1986
New delivery systems for hormonal contraception.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1986, Volume: 134

    Topics: Contraceptive Agents, Female; Drug Implants; Female; Humans; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Pregnancy; Progesterone; Progestins; Research; Time Factors; Vagina

1986
Long acting contraceptives. Present status.
    Drugs, 1983, Volume: 25, Issue:6

    Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Drug Combinations; Drug Implants; Estradiol Congeners; Female; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Progestins

1983
A comprehensive review of injectable contraception with special emphasis on depot medroxyprogesterone acetate.
    The Medical journal of Australia, 1981, 01-24, Volume: 1, Issue:SP1

    Topics: Australia; Blood Pressure; Breast Neoplasms; Contraceptives, Oral; Drug Implants; Female; Fertility; Fetus; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Neoplasms; Norethindrone; Thrombophlebitis; Uterine Cervical Neoplasms

1981
Animal toxicity studies performed for risk assessment of the once-a-month injectable contraceptive Mesigyna.
    Contraception, 1994, Volume: 49, Issue:4

    Topics: Animals; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Combinations; Estradiol; Humans; Injections, Intramuscular; Neoplasms, Experimental; Norethindrone; Risk Factors

1994
Metabolic effects of once-a-month combined injectable contraceptives. The World Health Organization Task Force on Long-Acting Systemic Agents for Fertility Regulation, Geneva, Switzerland.
    Contraception, 1994, Volume: 49, Issue:5

    Topics: 17 alpha-Hydroxyprogesterone Caproate; Algestone Acetophenide; Carbohydrate Metabolism; Contraceptive Agents, Female; Estradiol; Female; Hemostasis; Humans; Hydroxyprogesterones; Injections; Lipid Metabolism; Medroxyprogesterone Acetate; Norethindrone

1994
Current status of injectable hormonal contraception, with special reference to the monthly method.
    Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1997, Volume: 13, Issue:4

    Topics: Contraceptive Agents, Female; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Pregnancy

1997
Not all progestins are the same: implications for usage.
    Trends in pharmacological sciences, 2004, Volume: 25, Issue:11

    Topics: Contraceptives, Oral, Synthetic; Humans; Medroxyprogesterone; Norethindrone; Progesterone Congeners; Structure-Activity Relationship

2004
Depot medroxyprogesterone versus norethisterone oenanthate for long-acting progestogenic contraception.
    The Cochrane database of systematic reviews, 2006, Jul-19, Issue:3

    Topics: Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic

2006
Oestrogens and progestins for preventing and treating postpartum depression.
    The Cochrane database of systematic reviews, 2008, Oct-08, Issue:4

    Topics: Depression, Postpartum; Estrogens; Female; Humans; Norethindrone; Progestins; Randomized Controlled Trials as Topic

2008
The struggle for male hormonal contraception.
    Best practice & research. Clinical endocrinology & metabolism, 2011, Volume: 25, Issue:2

    Topics: Azoospermia; Clinical Trials as Topic; Contraception; Contraceptive Agents, Male; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Pregnancy Rate; Progesterone Congeners; Progestins; Testosterone

2011
Steroid hormones for contraception in men.
    The Cochrane database of systematic reviews, 2012, Mar-14, Issue:3

    Topics: Azoospermia; Contraception; Contraceptive Agents, Male; Contraceptives, Oral, Hormonal; Contraceptives, Oral, Synthetic; Desogestrel; Drug Implants; Humans; Levonorgestrel; Male; Norethindrone; Oligospermia; Randomized Controlled Trials as Topic; Testosterone

2012
Combination injectable contraceptives for contraception.
    The Cochrane database of systematic reviews, 2013, Volume: 3

    Topics: Algestone; Contraception; Contraceptive Agents, Female; Drug Combinations; Estradiol; Female; Humans; Injections; Medication Adherence; Medroxyprogesterone; Megestrol Acetate; Norethindrone; Randomized Controlled Trials as Topic

2013
Use of hormonal contraceptives and HIV acquisition in women: a systematic review of the epidemiological evidence.
    The Lancet. Infectious diseases, 2013, Volume: 13, Issue:9

    Topics: Aniline Compounds; Condoms, Female; Contraception; Contraceptives, Oral, Hormonal; Databases, Factual; Female; HIV Infections; Humans; Maternal Mortality; Norethindrone; Pregnancy; Pregnancy Rate; Reproducibility of Results; Risk Factors

2013
Differential glucocorticoid receptor-mediated effects on immunomodulatory gene expression by progestin contraceptives: implications for HIV-1 pathogenesis.
    American journal of reproductive immunology (New York, N.Y. : 1989), 2014, Volume: 71, Issue:6

    Topics: Africa South of the Sahara; Contraceptive Agents; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Female; HIV Infections; HIV-1; Humans; Immunosuppression Therapy; Medroxyprogesterone Acetate; Norethindrone; Progesterone Congeners; Receptors, Glucocorticoid

2014
Hormonal contraceptive methods and risk of HIV acquisition in women: a systematic review of epidemiological evidence.
    Contraception, 2014, Volume: 90, Issue:4

    Topics: Administration, Oral; Africa; Condoms; Contraceptive Agents, Female; Female; HIV Infections; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone

2014
Hormonal contraception and the risk of HIV acquisition: an individual participant data meta-analysis.
    PLoS medicine, 2015, Volume: 12, Issue:1

    Topics: Adolescent; Adult; Africa South of the Sahara; Contraceptive Agents, Female; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Risk Factors

2015
Ectopic pregnancy with use of progestin-only injectables and contraceptive implants: a systematic review.
    Contraception, 2015, Volume: 92, Issue:6

    Topics: Contraception; Contraceptive Agents, Female; Desogestrel; Drug Implants; Female; Humans; Incidence; Injections; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Pregnancy, Ectopic; Progestins

2015
Hormonal contraceptive use and women's risk of HIV acquisition: priorities emerging from recent data.
    Current opinion in obstetrics & gynecology, 2015, Volume: 27, Issue:6

    Topics: Adult; Contraceptive Agents, Female; Female; Health Knowledge, Attitudes, Practice; Health Priorities; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Norethindrone; Public Health; Risk Assessment; Risk Factors; Sexual Behavior

2015

Trials

47 trial(s) available for norethindrone and norethindrone enanthate

ArticleYear
Serum lipid variations in women on copper intrauterine devices, triphasic oral contraceptives and monthly injectable contraceptives.
    Contraception, 1991, Volume: 44, Issue:3

    Topics: Adult; Cholesterol, HDL; Cholesterol, LDL; Contraceptives, Oral; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Intrauterine Devices, Copper; Lipids; Longitudinal Studies; Norethindrone; Norpregnenes; Prospective Studies; Time Factors; Triglycerides

1991
A multicentred, two-year, phase III clinical trial of norethisterone enanthate 50 mg plus estradiol valerate 5 mg as a monthly injectable contraceptive.
    Contraception, 1991, Volume: 44, Issue:6

    Topics: Adolescent; Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Drug Therapy, Combination; Dysmenorrhea; Estradiol; Family Planning Services; Female; Humans; Incidence; Injections; Menorrhagia; Menstrual Cycle; Norethindrone; Time Factors

1991
Contraception with progestogens and progesterone during lactation.
    The Journal of steroid biochemistry and molecular biology, 1991, Volume: 40, Issue:4-6

    Topics: Contraceptive Devices, Female; Humans; Infant Nutritional Physiological Phenomena; Infant, Newborn; Lactation; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk, Human; Norethindrone; Progesterone; Psychophysiology

1991
Effect of long-acting progestagen-only injectable contraceptives on carbohydrate metabolism and its hormonal profile.
    Contraception, 1991, Volume: 44, Issue:4

    Topics: Blood Glucose; Carbohydrate Metabolism; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Female; Growth Hormone; Humans; Hydrocortisone; Insulin; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pyruvates; Radioimmunoassay; Time Factors

1991
A study of bleeding patterns with two injectable contraceptives given postpartum and the effect of two non-hormonal treatments.
    Advances in contraception : the official journal of the Society for the Advancement of Contraception, 1991, Volume: 7, Issue:4

    Topics: Contraceptive Agents, Female; Double-Blind Method; Female; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Naproxen; Norethindrone; Postpartum Period; Pregnancy; Tranexamic Acid; Uterine Hemorrhage

1991
A multicentre phase III comparative study of two hormonal contraceptive preparations NET-OEN (50 mg) + E2 valerate (5 mg) given every month and NET-OEN (200 mg) given every 2 months as intramuscular injection--a report of 12-month study. Indian Council of
    Contraception, 1990, Volume: 42, Issue:2

    Topics: Adolescent; Adult; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Drug Combinations; Estradiol; Estrogens, Conjugated (USP); Female; Humans; Injections, Intramuscular; Menstruation; Multicenter Studies as Topic; Norethindrone; Patient Dropouts; Randomized Controlled Trials as Topic

1990
Hemostatic changes in women using a monthly injectable contraceptive for one year.
    Contraception, 1990, Volume: 42, Issue:4

    Topics: Adult; Blood Coagulation; Contraceptive Agents, Female; Estradiol; Factor VIII; Factor X; Female; Fibrinogen; Follicular Phase; Hemoglobins; Humans; Injections, Intramuscular; Leukocyte Count; Longitudinal Studies; Luteal Phase; Norethindrone; Prospective Studies; Prothrombin Time

1990
Estrogen-progestogen once-a-month injectable contraceptives and serum prolactin.
    Contraception, 1989, Volume: 39, Issue:5

    Topics: Adult; Algestone Acetophenide; Contraceptives, Oral, Combined; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Estradiol; Female; Humans; Injections; Intrauterine Devices, Copper; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Prolactin; Random Allocation

1989
A study of adrenal corticol function and its reserve activity in long-acting injectable contraceptive users.
    Contraception, 1988, Volume: 37, Issue:5

    Topics: Adrenal Cortex; Adult; Blood Glucose; Contraceptive Agents, Female; Drug Evaluation; Female; Humans; Hydrocortisone; Hypoglycemia; Injections, Intravenous; Insulin; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone

1988
Acceptability of injectable contraceptives in Assiut, Egypt.
    Contraception, 1988, Volume: 38, Issue:6

    Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Evaluation; Egypt; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Pregnancy; Pregnancy, Unwanted

1988
ICMR (Indian Council of Medical Research) Task Force on Hormonal Contraception. Return of fertility following discontinuation of an injectable contraceptive--norethisterone oenanthate (NET EN) 200mg dose. Council of Medical Research.
    Contraception, 1986, Volume: 34, Issue:6

    Topics: Adult; Clinical Trials as Topic; Contraceptive Agents, Female; Female; Fertility; Humans; India; Injections; Norethindrone

1986
Indian Council of Medical Research. Task Force on Hormonal Contraception: Phase II randomized clinical trial with norethisterone oenanthate 50 mg alone and in combination with 5 mg or 2.5 mg of either estradiol valerate or cypionate as a monthly injectabl
    Contraception, 1985, Volume: 32, Issue:4

    Topics: Adult; Amenorrhea; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Estradiol; Female; Humans; Injections; Menstruation; Menstruation Disturbances; Norethindrone; Oligomenorrhea; Random Allocation; Time Factors

1985
Phase IV study of the injection Norigest in Pakistan.
    Contraception, 1985, Volume: 32, Issue:4

    Topics: Adolescent; Adult; Amenorrhea; Clinical Trials as Topic; Contraceptive Agents, Female; Female; Humans; Injections; Menstruation Disturbances; Norethindrone; Pakistan; Parity; Time Factors

1985
Effect of norethisterone enanthate on the blood count and endometrial histology of Indian women.
    Contraception, 1985, Volume: 32, Issue:4

    Topics: Blood Cells; Clinical Trials as Topic; Contraceptive Agents, Female; Endometrium; Eosinophils; Erythrocyte Count; Female; Hemoglobins; Humans; Injections; Leukocyte Count; Norethindrone; Time Factors

1985
Multinational comparative clinical trial of long-acting injectable contraceptives: norethisterone enanthate given in two dosage regimens and depot-medroxyprogesterone acetate. Final report.
    Contraception, 1983, Volume: 28, Issue:1

    Topics: Adult; Amenorrhea; Clinical Trials as Topic; Contraception; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Administration Schedule; Female; Fertility; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy

1983
Comparative evaluation of contraceptive efficacy of norethisterone oenanthate (200 mg) injectable contraceptive given every two or three monthly. Indian Council of Medical Research Task Force on Hormonal Contraception.
    Contraception, 1984, Volume: 30, Issue:6

    Topics: Adult; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Administration Schedule; Female; Fertility; Humans; India; Injections, Intramuscular; Norethindrone; Pregnancy; Risk

1984
A prospective controlled study of the effect on blood pressure of contraceptive preparations containing different types and dosages of progestogen.
    British journal of obstetrics and gynaecology, 1984, Volume: 91, Issue:12

    Topics: Adolescent; Adult; Blood Pressure; Clinical Trials as Topic; Contraceptives, Oral; Contraceptives, Oral, Combined; Ethinyl Estradiol; Ethynodiol Diacetate; Female; Humans; Levonorgestrel; Middle Aged; Norethindrone; Norethindrone Acetate; Norgestrel; Prospective Studies; Stereoisomerism

1984
A randomized, single blind comparative trial of norethindrone enanthate and depo-medroxyprogesterone acetate in Bangladesh.
    Contraception, 1980, Volume: 21, Issue:3

    Topics: Adult; Amenorrhea; Bangladesh; Clinical Trials as Topic; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Pregnancy; Random Allocation

1980
WHO special programme of research, development and research training in human reproduction. Task force on long-acting agents for the regulation of fertility.
    Contraception, 1982, Volume: 25, Issue:1

    Topics: Amenorrhea; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Administration Schedule; Female; Humans; Injections, Intravenous; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; World Health Organization

1982
Effects of synthetic steroid contraceptives on biliary lipid composition of normal Mexican women.
    Contraception, 1983, Volume: 27, Issue:6

    Topics: Adult; Bile; Bile Acids and Salts; Cholesterol; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Humans; Lipids; Mexico; Norethindrone; Norgestrel; Phosphatidylcholines; Prospective Studies; Random Allocation

1983
Phase I clinical trial of two contraceptive preparations. Norethisterone enanthate (NEN) and norethisterone acetate (NET).
    Contraception, 1981, Volume: 23, Issue:2

    Topics: Blood Glucose; Cholesterol; Drug Evaluation; Female; Follicle Stimulating Hormone; Humans; Insulin; Kidney; Liver; Menstruation; Norethindrone; Norethindrone Acetate; Thyroid Gland; Time Factors; Triglycerides

1981
Low dose injectable contraceptive norethisterone enanthate 200 mg monthly clinical trials.
    Contraception, 1981, Volume: 24, Issue:2

    Topics: Clinical Trials as Topic; Female; Humans; Norethindrone; Pregnancy

1981
A clinical trial of norethisterone oenanthate (Norigest) injected every two months.
    Contraception, 1982, Volume: 25, Issue:4

    Topics: Amenorrhea; Blood Pressure; Body Weight; Clinical Trials as Topic; Contraceptive Agents, Female; Drug Administration Schedule; Female; Humans; Injections, Intramuscular; Menstruation; Norethindrone

1982
Multicentred, phase III clinical trial of norethisterone enanthate 50 mg plus estradiol valerate 5 mg as a monthly injectable contraceptive; final three-year report.
    Contraception, 1994, Volume: 50, Issue:4

    Topics: Amenorrhea; Body Weight; Contraceptive Agents, Female; Estradiol; Female; Humans; Injections; Latin America; Norethindrone; Pregnancy; Uterine Hemorrhage

1994
Progestogen-only contraceptives during lactation: I. Infant growth. World Health Organization Task force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development and Research Training in Human Reproduction.
    Contraception, 1994, Volume: 50, Issue:1

    Topics: Adolescent; Adult; Anthropometry; Body Weight; Child Development; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Humans; Hungary; Infant; Kenya; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Prospective Studies; Thailand

1994
Progestogen-only contraceptives during lactation: II. Infant development. World Health Organization, Task Force for Epidemiological Research on Reproductive Health; Special Programme of Research, Development, and Research Training in Human Reproduction.
    Contraception, 1994, Volume: 50, Issue:1

    Topics: Adolescent; Adult; Child Development; Chile; Contraceptive Agents, Female; Drug Implants; Egypt; Female; Humans; Hungary; Infant; Kenya; Lactation; Levonorgestrel; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Prospective Studies; Thailand

1994
A double-blind randomised placebo controlled trial of postnatal norethisterone enanthate: the effect on postnatal depression and serum hormones.
    British journal of obstetrics and gynaecology, 1998, Volume: 105, Issue:10

    Topics: Adult; Contraceptives, Oral, Synthetic; Depression, Postpartum; Double-Blind Method; Estradiol; Female; Humans; Norethindrone; Postnatal Care; Pregnancy; Progesterone; Prognosis; Risk Factors; Testosterone; Uterine Hemorrhage

1998
Potential of norethisterone enanthate for male contraception: pharmacokinetics and suppression of pituitary and gonadal function.
    Clinical endocrinology, 2000, Volume: 53, Issue:3

    Topics: Adult; Analysis of Variance; Contraceptive Agents, Male; Depression, Chemical; Humans; Libido; Luteinizing Hormone; Male; Norethindrone; Pituitary Gland; Prostate; Sex Hormone-Binding Globulin; Sexuality; Sperm Count; Testis; Testosterone; Ultrasonography

2000
Intramuscular testosterone undecanoate and norethisterone enanthate in a clinical trial for male contraception.
    The Journal of clinical endocrinology and metabolism, 2001, Volume: 86, Issue:1

    Topics: Adult; Alkaline Phosphatase; Contraceptive Agents, Male; Drug Combinations; Follicle Stimulating Hormone; Humans; Injections, Intramuscular; Lipids; Luteinizing Hormone; Male; Norethindrone; Prostate; Semen; Sexual Behavior; Sperm Count; Sperm Motility; Testis; Testosterone; Ultrasonography

2001
An effective hormonal male contraceptive using testosterone undecanoate with oral or injectable norethisterone preparations.
    The Journal of clinical endocrinology and metabolism, 2002, Volume: 87, Issue:2

    Topics: Administration, Oral; Adult; Blood; Coitus; Contraceptive Agents, Male; Contraceptives, Oral, Synthetic; Drug Synergism; Hormones; Humans; Injections, Intramuscular; Lipids; Male; Middle Aged; Norethindrone; Prostate; Sperm Count; Spermatogenesis; Testis; Testosterone; Testosterone Congeners

2002
Pharmacokinetics of a new transdermal testosterone gel in gonadotrophin-suppressed normal men.
    European journal of endocrinology, 2002, Volume: 146, Issue:5

    Topics: Adult; Dose-Response Relationship, Drug; Gels; Gonadotropins; Hormone Replacement Therapy; Humans; Injections, Intramuscular; Male; Norethindrone; Testosterone

2002
Menstrual pattern and lipid profiles during use of medroxyprogesterone acetate and estradiol cypionate and NET-EN (200 mg) as contraceptive injections.
    Contraception, 2004, Volume: 69, Issue:2

    Topics: Adolescent; Adult; Cholesterol; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Lipids; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Norethindrone

2004
Use of norethisterone oenanthate and predisposition to thrombosis.
    Journal of the College of Physicians and Surgeons--Pakistan : JCPSP, 2004, Volume: 14, Issue:9

    Topics: Adult; Blood Coagulation; Blood Coagulation Tests; Contraceptive Agents, Female; Female; Humans; Middle Aged; Norethindrone; Pakistan

2004
Norethisterone enanthate plus testosterone undecanoate for male contraception: effects of various injection intervals on spermatogenesis, reproductive hormones, testis, and prostate.
    The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:4

    Topics: Adolescent; Adult; Contraception; Drug Combinations; Follicle Stimulating Hormone; Humans; Injections; Luteinizing Hormone; Male; Middle Aged; Norethindrone; Prospective Studies; Prostate; Sperm Count; Spermatogenesis; Testis; Testosterone

2005
Acceptability of an injectable male contraceptive regimen of norethisterone enanthate and testosterone undecanoate for men.
    Human reproduction (Oxford, England), 2006, Volume: 21, Issue:8

    Topics: Adult; Affect; Attitude; Contraception Behavior; Contraceptive Agents, Male; Drug Combinations; Humans; Injections, Intramuscular; Male; Norethindrone; Patient Acceptance of Health Care; Sexual Behavior; Testosterone

2006
Prospective study of hormonal contraception and women's risk of HIV infection in South Africa.
    International journal of epidemiology, 2007, Volume: 36, Issue:1

    Topics: Adult; Age Distribution; Contraceptives, Oral; Contraceptives, Oral, Combined; Contraceptives, Oral, Hormonal; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Prospective Studies; Risk Factors; Sexual Behavior; Sexually Transmitted Diseases; South Africa; Time Factors; Uterine Cervical Neoplasms

2007
A placebo-controlled, randomized clinical trial using testosterone undecanoate with injectable norethisterone enanthate: effect on anthropometric, metabolic and biochemical parameters.
    International journal of andrology, 2011, Volume: 34, Issue:6 Pt 1

    Topics: Adult; Anthropometry; Body Mass Index; Humans; Male; Norethindrone; Placebos; Testosterone

2011
Hormonal contraception and the risk of HIV acquisition among women in South Africa.
    AIDS (London, England), 2012, Feb-20, Volume: 26, Issue:4

    Topics: Adolescent; Adult; Anti-Infective Agents; Contraceptives, Oral, Hormonal; Female; HIV Seropositivity; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Odds Ratio; Pregnancy; Proportional Hazards Models; Sexual Behavior; South Africa; Vaginal Creams, Foams, and Jellies; Young Adult

2012
Risk of HIV-1 acquisition among women who use diff erent types of injectable progestin contraception in South Africa: a prospective cohort study.
    The lancet. HIV, 2015, Volume: 2, Issue:7

    Topics: Adult; Cohort Studies; Contraception Behavior; Contraceptive Agents, Female; Female; Follow-Up Studies; HIV Infections; HIV-1; Humans; Incidence; Medroxyprogesterone Acetate; Norethindrone; Proportional Hazards Models; Risk Factors; South Africa; Tenofovir; Young Adult

2015
Effects of the copper intrauterine device versus injectable progestin contraception on pregnancy rates and method discontinuation among women attending termination of pregnancy services in South Africa: a pragmatic randomized controlled trial.
    Reproductive health, 2016, Apr-18, Volume: 13

    Topics: Abdominal Pain; Abortion, Legal; Adolescent; Adult; Back Pain; Contraception Behavior; Contraceptive Agents, Female; Drug Implants; Early Termination of Clinical Trials; Female; Follow-Up Studies; Humans; Intrauterine Devices, Copper; Lost to Follow-Up; Medroxyprogesterone Acetate; Norethindrone; Postoperative Period; Pregnancy; Pregnancy Rate; Progestins; South Africa; Young Adult

2016
Efficacy and Safety of an Injectable Combination Hormonal Contraceptive for Men.
    The Journal of clinical endocrinology and metabolism, 2016, Volume: 101, Issue:12

    Topics: Adolescent; Adult; Androgens; Contraception; Contraceptive Agents; Drug Therapy, Combination; Female; Humans; Injections, Intramuscular; Male; Norethindrone; Outcome Assessment, Health Care; Pregnancy; Prospective Studies; Spermatogenesis; Testosterone; Young Adult

2016
Brief Report: Dapivirine Vaginal Ring Use Does Not Diminish the Effectiveness of Hormonal Contraception.
    Journal of acquired immune deficiency syndromes (1999), 2017, 10-01, Volume: 76, Issue:2

    Topics: Adolescent; Adult; Anti-Retroviral Agents; Contraception; Contraceptive Agents, Female; Contraceptive Devices, Female; Contraceptives, Oral, Hormonal; Double-Blind Method; Drug Interactions; Female; Follow-Up Studies; HIV Infections; Humans; Incidence; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Pregnancy; Pyrimidines; Young Adult

2017
Impact of Hormonal Contraceptives on Cervical T-helper 17 Phenotype and Function in Adolescents: Results from a Randomized, Crossover Study Comparing Long-acting Injectable Norethisterone Oenanthate (NET-EN), Combined Oral Contraceptive Pills, and Combine
    Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2020, 10-23, Volume: 71, Issue:7

    Topics: Adolescent; Africa South of the Sahara; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Cross-Over Studies; Female; Humans; Norethindrone; Phenotype; Pregnancy

2020
Hormonal contraception and risk of STIs and bacterial vaginosis in South African adolescents: secondary analysis of a randomised trial.
    Sexually transmitted infections, 2021, Volume: 97, Issue:2

    Topics: Adolescent; Bacteria; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Cross-Over Studies; Female; Hormonal Contraception; Humans; Incidence; Intention to Treat Analysis; Norethindrone; Risk; Sexually Transmitted Diseases; South Africa; Species Specificity; Vagina; Vaginosis, Bacterial; Young Adult

2021
Hormonal contraception alters vaginal microbiota and cytokines in South African adolescents in a randomized trial.
    Nature communications, 2020, 11-04, Volume: 11, Issue:1

    Topics: Adolescent; Africa South of the Sahara; Contraceptive Devices, Female; Contraceptives, Oral, Combined; Cross-Over Studies; Cytokines; Female; HIV Infections; Hormonal Contraception; Humans; Microbiota; Norethindrone; RNA, Ribosomal, 16S; T-Lymphocytes; Vagina; Young Adult

2020
Effect of injectable progestin-only contraceptives, depot medroxyprogesterone acetate and norethisterone enanthate, on cytokine production during T-cell activation.
    American journal of reproductive immunology (New York, N.Y. : 1989), 2021, Volume: 86, Issue:1

    Topics: CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Contraceptive Agents, Female; Female; Humans; Injections; Interferon-gamma; Intrauterine Devices, Copper; Lymphocyte Activation; Medroxyprogesterone Acetate; Norethindrone; Progestins; Young Adult

2021
Comparison of Female Genital Tract Cytokine and Microbiota Signatures Induced by Initiation of Intramuscular DMPA and NET-EN Hormonal Contraceptives - a Prospective Cohort Analysis.
    Frontiers in immunology, 2021, Volume: 12

    Topics: Adolescent; Adult; Africa South of the Sahara; Contraceptive Agents, Female; Contraceptive Agents, Hormonal; Cross-Over Studies; Cytokines; Female; Genitalia, Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Microbiota; Norethindrone; Prospective Studies; RNA, Ribosomal, 16S; Sexually Transmitted Diseases; Vaginosis, Bacterial; Young Adult

2021

Other Studies

105 other study(ies) available for norethindrone and norethindrone enanthate

ArticleYear
Long-term use of depot-norethisterone enanthate: effect on blood lipid fractions.
    Contraception, 1992, Volume: 46, Issue:1

    Topics: Adult; Blood Pressure; Cholesterol; Contraceptive Agents, Female; Female; Humans; Injections, Intramuscular; Lipids; Lipoproteins, HDL; Lipoproteins, LDL; Middle Aged; Norethindrone; Odds Ratio; Triglycerides

1992
A prospective, one-year study on the effects of two long acting injectable contraceptives (depot-medroxyprogesterone acetate and norethisterone oenanthate) on serum and lipoprotein lipids.
    Hormone and metabolic research = Hormon- und Stoffwechselforschung = Hormones et metabolisme, 1992, Volume: 24, Issue:2

    Topics: Adult; Apolipoproteins; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Female; Humans; Injections; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Time Factors; Triglycerides

1992
Long-term use of depot-norethisterone enanthate: effect on blood coagulation factors and menstrual bleeding patterns.
    Contraception, 1991, Volume: 44, Issue:6

    Topics: Adult; Amenorrhea; Antigens; Antithrombin III; Blood Coagulation Factors; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Erythrocyte Count; Erythrocyte Volume; Factor VII; Factor X; Female; Hemoglobins; Humans; Injections; Menstruation; Middle Aged; Norethindrone; Time Factors

1991
[Pharmacokinetics of norethindrone enanthate 200 mg after intramuscular injection in 25 Chinese women].
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1991, Volume: 12, Issue:2

    Topics: Adult; Asian People; Female; Humans; Injections, Intramuscular; Norethindrone; Progesterone Congeners; White People

1991
Effect of norethisterone enanthate on endometrial bleeding and changes in coagulation function, ovarian hormones and endometrial histology in Thai women.
    Contraception, 1991, Volume: 44, Issue:1

    Topics: Adult; Blood Coagulation; Contraceptive Agents, Female; Endometrium; Female; Gonadal Steroid Hormones; Humans; Menstrual Cycle; Norethindrone; Thailand

1991
The effects of long-term using once-a-month injectable contraceptive norethisterone enanthate/estradiol valerate on coagulation in the Chinese.
    Thrombosis and haemostasis, 1990, Dec-28, Volume: 64, Issue:4

    Topics: Adult; Blood Coagulation; China; Contraceptive Agents, Female; Drug Administration Schedule; Estradiol; Female; Fibrinolysis; Humans; Injections; Longitudinal Studies; Norethindrone; Risk Factors

1990
[Doctors and injectable contraception. Analysis of the logistics of prescribing in accordance with the views expressed by doctors].
    Journal de gynecologie, obstetrique et biologie de la reproduction, 1990, Volume: 19, Issue:2

    Topics: Attitude of Health Personnel; Attitude to Health; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Cultural Characteristics; Family Planning Services; Female; France; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Patient Care Team; Physician-Patient Relations; Practice Patterns, Physicians'; Socioeconomic Factors

1990
Progestins modulate the action of estrogen on gonadotropin-releasing hormone, luteinizing hormone and prolactin in the rat.
    Gynecologic and obstetric investigation, 1990, Volume: 29, Issue:3

    Topics: Animals; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Desogestrel; Estrogens; Female; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Pituitary Gland; Pituitary Hormone-Releasing Hormones; Progestins; Prolactin; Radioimmunoassay; Rats; Rats, Inbred Strains

1990
The toxic pathophysiology of retinol hypervitaminosis and norethisterone enantate in rats.
    Journal of the Egyptian Society of Parasitology, 1990, Volume: 20, Issue:1

    Topics: Animals; Contraceptives, Oral, Synthetic; Female; Hypervitaminosis A; Kidney; Liver; Norethindrone; Ovary; Rats

1990
Alterations in protein, sialic acid and some enzymes in cervical mucus of female rats during NET-EN treatment.
    Contraception, 1987, Volume: 36, Issue:2

    Topics: Alkaline Phosphatase; Amylases; Animals; Cervix Mucus; Contraceptives, Oral, Synthetic; Electrophoresis, Polyacrylamide Gel; Estrus; Female; Norethindrone; Proteins; Rats; Rats, Inbred Strains; Sialic Acids; Time Factors

1987
Serum progesterone and norethisterone levels following injection of norethisterone enanthate in different sites and doses.
    Steroids, 1989, Volume: 53, Issue:6

    Topics: Adult; Anovulation; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Female; Humans; Injections, Intramuscular; Menstruation; Norethindrone; Progesterone

1989
Effect of Depo-Provera and Noristerat on some biochemical constituents of rat uterus.
    Indian journal of experimental biology, 1986, Volume: 24, Issue:3

    Topics: Acid Phosphatase; Alkaline Phosphatase; Animals; Contraceptive Agents, Female; Female; Lipid Metabolism; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Rats; Rats, Inbred Strains; Uterus

1986
Menstrual changes associated with progestogen-only contraception.
    Acta obstetricia et gynecologica Scandinavica. Supplement, 1986, Volume: 134

    Topics: Administration, Oral; Amenorrhea; Contraceptive Agents, Female; Counseling; Estrogens; Female; Humans; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstruation Disturbances; Norethindrone; Norgestrel; Time Factors

1986
Pharmacokinetics of norethindrone oenanthate in 5 women after a single dose of norethindrone oenanthate and estradiol valerate.
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1986, Volume: 7, Issue:3

    Topics: Adult; Biological Availability; Contraceptives, Oral, Synthetic; Estradiol; Female; Half-Life; Humans; Kinetics; Norethindrone

1986
New regimen of injectable contraceptives.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1987, Volume: 70, Issue:4

    Topics: Adult; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone

1987
Pituitary response to LHRH in long-term users of injectable contraceptives.
    Contraception, 1987, Volume: 35, Issue:5

    Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Injections; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone

1987
[Parenteral contraceptive drugs: depot progestins].
    Wiener medizinische Wochenschrift (1946), 1987, Nov-15, Volume: 137, Issue:20-21

    Topics: Administration, Intravaginal; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Implants; Female; Humans; Injections; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstrual Cycle; Norethindrone; Pregnancy

1987
Histological changes in the ovary and uterus of rat after injectable contraceptive therapy.
    Contraception, 1988, Volume: 37, Issue:5

    Topics: Animals; Contraception; Contraceptive Agents; Female; Injections, Subcutaneous; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Ovary; Rats; Rats, Inbred Strains; Uterus

1988
Progesterone and progestins modulate beta-endorphin concentrations in the hypothalamus and in the pituitary of castrated female rats.
    Gynecological endocrinology : the official journal of the International Society of Gynecological Endocrinology, 1987, Volume: 1, Issue:1

    Topics: Animals; beta-Endorphin; Desogestrel; Estradiol; Female; Hypothalamus, Middle; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norpregnenes; Ovariectomy; Pituitary Gland; Pituitary Gland, Anterior; Progesterone; Progestins; Radioimmunoassay; Rats; Rats, Inbred Strains

1987
Investigations upon the mechanism of inhibition of spermatogenesis in the rat by a dimeric ethynodiol-testosterone ester.
    Acta endocrinologica, 1988, Volume: 117, Issue:4

    Topics: Androgen-Binding Protein; Animals; Ethynodiol Diacetate; Follicle Stimulating Hormone; Luteinizing Hormone; Male; Norethindrone; Rats; Rats, Inbred Strains; Spermatogenesis; Testis; Testosterone

1988
[Restoration of pituitary-ovarian function after long-term application of combined norethindrone oenanthate].
    Zhonghua fu chan ke za zhi, 1988, Volume: 23, Issue:5

    Topics: Adult; Contraceptive Agents, Female; Female; Follicle Stimulating Hormone; Humans; Injections, Intramuscular; Luteinizing Hormone; Norethindrone; Ovary; Ovulation; Pituitary Gland

1988
[Effectiveness of injectable contraceptives in Mexican women].
    Boletin de la Oficina Sanitaria Panamericana. Pan American Sanitary Bureau, 1985, Volume: 98, Issue:2

    Topics: Adolescent; Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Evaluation; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Mexico; Norethindrone; Patient Acceptance of Health Care; Patient Dropouts; Pregnancy

1985
Return to ovulation following the use of long-acting injectable contraceptives: a comparative study.
    Contraception, 1985, Volume: 31, Issue:4

    Topics: Adult; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menstrual Cycle; Norethindrone; Ovulation; Progesterone; Time Factors

1985
Long-term use of an injectable contraceptive: effect of depot-norethisterone oenanthate on carbohydrate metabolism.
    Contraception, 1988, Volume: 37, Issue:1

    Topics: Adult; Blood Glucose; Carbohydrate Metabolism; Delayed-Action Preparations; Fasting; Female; Glucose Tolerance Test; Humans; Insulin; Norethindrone; Time Factors

1988
Serum levels of norethisterone, estradiol and progesterone after administration of norethisterone oenanthate at different sites: a cross-over study.
    Asia-Oceania journal of obstetrics and gynaecology, 1987, Volume: 13, Issue:1

    Topics: Adult; Estradiol; Female; Humans; Injections, Intramuscular; Kinetics; Norethindrone; Progesterone

1987
[Effect of progesterone and norethisterone oenanthate on dynamic distribution of progesterone receptor in target cell].
    Sheng li xue bao : [Acta physiologica Sinica], 1987, Volume: 39, Issue:2

    Topics: Animals; Cell Nucleus; Contraceptives, Oral, Synthetic; Female; Norethindrone; Progesterone; Rabbits; Receptors, Progesterone; Uterus

1987
Effect of norethisterone enanthate on intestinal digestive and absorptive functions in protein deficient rat.
    Indian journal of gastroenterology : official journal of the Indian Society of Gastroenterology, 1987, Volume: 6, Issue:1

    Topics: Animals; Digestion; Female; Intestinal Absorption; Microvilli; Norethindrone; Protein Deficiency; Rats

1987
Dose- and time-dependent effects of a dimeric ethynodiol-testosterone depot-preparation in female rat.
    Endocrinologia experimentalis, 1985, Volume: 19, Issue:2

    Topics: Animals; Castration; Dose-Response Relationship, Drug; Drug Implants; Estradiol; Ethynodiol Diacetate; Female; Luteinizing Hormone; Norethindrone; Organ Size; Ovary; Pituitary Gland; Progesterone; Rats; Structure-Activity Relationship; Testosterone; Thymus Gland; Time Factors

1985
Introduction of the injectable contraceptive NET-EN into family planning clinics in Bangladesh.
    Bulletin of the World Health Organization, 1985, Volume: 63, Issue:4

    Topics: Adolescent; Adult; Bangladesh; Contraceptives, Oral, Synthetic; Family Planning Services; Female; Humans; Injections, Intramuscular; National Health Programs; Norethindrone

1985
Some metabolic effects of long-term use of the injectable contraceptive norethisterone oenanthate.
    Lancet (London, England), 1982, Feb-20, Volume: 1, Issue:8269

    Topics: Adult; Blood Coagulation; Cholesterol; Contraceptive Agents, Female; Cross-Sectional Studies; Female; Glucose Tolerance Test; Humans; Injections, Intramuscular; Lipoproteins, HDL; Middle Aged; Norethindrone; Time Factors; Triglycerides

1982
Response of unmarried adolescents to contraceptive advice and service in Nigeria.
    International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 1981, Volume: 19, Issue:6

    Topics: Adolescent; Contraception; Contraception Behavior; Contraceptive Agents, Female; Developing Countries; Family Planning Services; Female; Health Knowledge, Attitudes, Practice; Humans; Intrauterine Devices; Male; Nigeria; Norethindrone; Prospective Studies; Sex Education

1981
Long-acting progestins--promise and prospects.
    Population reports. Series K, Injectables and implants, 1983, Volume: 11, Issue:2

    Topics: Animals; Bibliographies as Topic; Breast Neoplasms; Contraceptives, Oral, Combined; Delayed-Action Preparations; Dogs; Female; Haplorhini; Humans; Injections, Intramuscular; Intrauterine Devices, Medicated; Levonorgestrel; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Progesterone Congeners; Rats; Reproduction; Uterine Neoplasms

1983
Neonatal exposure to a progestin via milk alters subsequent LH cyclicity in the female rat.
    The Journal of endocrinology, 1984, Volume: 100, Issue:2

    Topics: Animals; Animals, Newborn; Animals, Suckling; Female; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Milk; Norethindrone; Pregnancy; Proestrus; Progesterone; Progestins; Rats; Rats, Inbred Strains

1984
A survey of different approaches to management of menstrual disturbances in women using injectable contraceptives.
    Contraception, 1983, Volume: 28, Issue:4

    Topics: Amenorrhea; Contraceptive Agents, Female; Curettage; Estrogens; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Menorrhagia; Menstruation Disturbances; Norethindrone; Oligomenorrhea

1983
Injectable contraception.
    Clinics in obstetrics and gynaecology, 1984, Volume: 11, Issue:3

    Topics: Adult; Cervix Mucus; Contraceptive Agents, Female; Endometrium; Female; Humans; Injections, Intramuscular; Kinetics; Lactation; Lipid Metabolism; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Uterine Hemorrhage

1984
[Injectable contraception using depot progestagens].
    Ginecologia y obstetricia de Mexico, 1983, Volume: 51, Issue:315

    Topics: Animals; Contraceptive Agents, Female; Delayed-Action Preparations; Dogs; Embryonic and Fetal Development; Female; Fertility; Humans; Macaca mulatta; Mammary Neoplasms, Experimental; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Pregnancy

1983
Postabortal contraception with norethisterone enanthate injections.
    Contraception, 1983, Volume: 27, Issue:6

    Topics: Abortion, Legal; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Drug Administration Schedule; Estradiol; Female; Follicle Stimulating Hormone; Humans; Injections, Intramuscular; Luteinizing Hormone; Norethindrone; Pregnancy; Pregnancy Trimester, First; Progesterone; Time Factors

1983
Blood hormone levels in egyptian women on norethisterone oenanthate.
    Contraception, 1983, Volume: 28, Issue:1

    Topics: Adult; Animals; Contraceptive Agents, Female; Egypt; Estradiol; Female; Follicle Stimulating Hormone; Gonadotropins, Pituitary; Humans; Injections; Luteinizing Hormone; Norethindrone; Ovulation; Progesterone; Prolactin; Rats

1983
Serum copper and zinc in hormonal contraceptive users.
    Fertility and sterility, 1980, Volume: 33, Issue:3

    Topics: 20-alpha-Dihydroprogesterone; Contraceptive Devices, Female; Contraceptives, Oral; Contraceptives, Oral, Combined; Copper; Estradiol; Ethinyl Estradiol; Female; Humans; Medroxyprogesterone; Medroxyprogesterone Acetate; Norethindrone; Norgestrel; Zinc

1980
On the mechanism of action of progestins.
    Acta endocrinologica, 1981, Volume: 97, Issue:3

    Topics: Castration; Female; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Humans; Luteinizing Hormone; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Pituitary Gland; Progesterone; Progesterone Congeners; Receptors, Androgen

1981
[Metabolism of [6, 7-3H] norethisterone enanthate in rats (author's transl)].
    Zhongguo yao li xue bao = Acta pharmacologica Sinica, 1981, Volume: 2, Issue:1

    Topics: Animals; Contraceptives, Oral; Contraceptives, Oral, Hormonal; Female; Metabolic Clearance Rate; Norethindrone; Rats; Tissue Distribution; Tritium

1981
Mechanism of action of contraceptive synthetic progestins.
    Journal of steroid biochemistry, 1981, Volume: 15

    Topics: Androgen-Insensitivity Syndrome; Animals; Female; Follicle Stimulating Hormone; Humans; Luteinizing Hormone; Male; Medroxyprogesterone; Medroxyprogesterone Acetate; Menopause; Norethindrone; Ovary; Rabbits; Rats; Receptors, Steroid; Sheep

1981
Studies on some enzymes and sialic acid during progestational contraceptive therapy.
    Contraception, 1984, Volume: 29, Issue:6

    Topics: Acetylcholinesterase; Acid Phosphatase; Adult; Alanine Transaminase; Alkaline Phosphatase; Aspartate Aminotransferases; Enzymes; Female; Humans; Liver; N-Acetylneuraminic Acid; Norethindrone; Sialic Acids

1984
Pharmacokinetics, pharmacodynamic and endometrial effects of a single dose of 200 mg norethisterone enanthate.
    Contraception, 1984, Volume: 30, Issue:3

    Topics: Adult; Endometrium; Female; Humans; Injections, Intramuscular; Kinetics; Norethindrone; Ovulation

1984
Norethisterone levels in maternal serum and milk after intramuscular injection of norethisterone oenanthate as a contraceptive.
    Contraception, 1983, Volume: 28, Issue:5

    Topics: Breast Feeding; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Female; Humans; Injections, Intramuscular; Milk, Human; Norethindrone; Time Factors

1983
[Use and effectiveness of norethisterone enanthate for family planning in a rural area].
    Ginecologia y obstetricia de Mexico, 1983, Volume: 51, Issue:314

    Topics: Adolescent; Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Drug Evaluation; Female; Health Knowledge, Attitudes, Practice; Humans; Injections, Intramuscular; Mexico; Norethindrone; Pregnancy; Rural Population

1983
The effect of injectable contraceptive on lipid metabolism in women.
    Biomedica biochimica acta, 1984, Volume: 43, Issue:1

    Topics: Adult; Cholesterol; Fatty Acids, Nonesterified; Female; Humans; Injections; Lipids; Norethindrone; Phospholipids; Triglycerides

1984
Pharmacokinetics of different doses of norethisterone oenanthate.
    Contraception, 1984, Volume: 29, Issue:4

    Topics: Adult; Contraceptives, Oral, Synthetic; Dose-Response Relationship, Drug; Estradiol; Female; Humans; Injections, Intramuscular; Kinetics; Male; Middle Aged; Norethindrone; Ovary; Ovulation; Progesterone; Regression Analysis

1984
Return of ovulation and fertility in women using norethisterone oenanthate.
    Contraception, 1984, Volume: 29, Issue:5

    Topics: Adult; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Estradiol; Female; Fertility; Humans; Menstruation; Norethindrone; Ovulation; Pregnancy; Progesterone

1984
Variability of pharmacokinetic parameters for contraceptive steroids.
    Journal of steroid biochemistry, 1983, Volume: 19, Issue:1C

    Topics: Biological Availability; Contraceptives, Oral; Contraceptives, Oral, Synthetic; Ethinyl Estradiol; Female; Half-Life; Humans; Kinetics; Norethindrone

1983
Effect of injectable norethisterone oenanthate (Norigest) on blood lipid levels.
    Contraception, 1982, Volume: 25, Issue:4

    Topics: Adult; Cholesterol; Cholesterol, HDL; Cholesterol, LDL; Cholesterol, VLDL; Contraceptive Agents, Female; Female; Humans; Lipids; Lipoproteins; Lipoproteins, HDL; Lipoproteins, LDL; Lipoproteins, VLDL; Middle Aged; Norethindrone; Obesity; Smoking

1982
Metabolism of injectable formulations of contraceptive steroids in obese and thin women.
    Contraception, 1982, Volume: 26, Issue:1

    Topics: Adult; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone; Norethindrone; Obesity; Progesterone; Time Factors

1982
Effect of norethisterone enanthate subdermal silastic implants on luteal function in rabbits.
    Endokrinologie, 1982, Volume: 80, Issue:1

    Topics: Animals; Corpus Luteum; Drug Implants; Female; Norethindrone; Pregnancy; Progesterone; Rabbits; Silicone Elastomers

1982
Effectiveness of norethisterone enantate in the treatment of the climacteic syndrome.
    Acta Europaea fertilitatis, 1982, Volume: 13, Issue:2

    Topics: Adult; Climacteric; Female; Gonadotropins; Humans; Middle Aged; Norethindrone; Prolactin

1982
Effect of norethisterone enanthate subdermal silastic implants on the ovary & uterus of adult rabbits.
    Indian journal of experimental biology, 1980, Volume: 18, Issue:11

    Topics: Animals; Drug Implants; Female; Norethindrone; Ovary; Rabbits; Silicone Elastomers; Uterus

1980
Studies on the enzymatic cleavage of norethisterone oenanthate.
    Contraception, 1981, Volume: 23, Issue:2

    Topics: Adipose Tissue; Adult; Aged; Animals; Dogs; Female; Gastric Mucosa; Goats; Humans; Hydrolysis; Intestinal Mucosa; Kidney; Liver; Male; Middle Aged; Muscles; Norethindrone; Organ Specificity; Rabbits; Rats; Species Specificity

1981
Pharmacokinetics of norethisterone oenanthate in humans.
    Contraception, 1981, Volume: 24, Issue:1

    Topics: Absorption; Adolescent; Adult; Biological Availability; Female; Half-Life; Humans; Kinetics; Male; Norethindrone

1981
Reversible inhibition of spermatogenesis by a long-acting dimeric ethynodiol-testosterone ester.
    Contraception, 1981, Volume: 24, Issue:1

    Topics: Animals; Antispermatogenic Agents; Dose-Response Relationship, Drug; Ethynodiol Diacetate; Female; Genitalia, Male; Kinetics; Luteinizing Hormone; Male; Norethindrone; Organ Size; Rabbits; Rats; Spermatogenesis; Testis; Testosterone

1981
Contraceptive efficacy of microdose norethisterone enanthate: a study on its use in polydimethylsiloxane implants.
    Indian journal of experimental biology, 1981, Volume: 19, Issue:5

    Topics: Animals; Dimethylpolysiloxanes; Drug Implants; Female; Norethindrone; Ovulation; Rabbits

1981
Plasma levels of norethidrone in Indian women receiving norethidrone enanthate (20 mg) injectable.
    Contraception, 1981, Volume: 23, Issue:5

    Topics: Adult; Anthropometry; Body Weight; Female; Humans; India; Injections, Intramuscular; Norethindrone; Ovulation; Progesterone

1981
Effect of norethisterone oenanthate-a long acting injectable contraceptive on cervical mucus changes in adult female virgin rats.
    Bangladesh Medical Research Council bulletin, 1981, Volume: 7, Issue:2

    Topics: Animals; Cervix Mucus; Female; Norethindrone; Proteins; Rats

1981
The effect of injectable norethisterone oenanthate on ovarian hormones in Thai women.
    Contraception, 1980, Volume: 21, Issue:3

    Topics: Adult; Contraceptives, Oral, Combined; Estradiol; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Norethindrone; Norgestrel; Ovulation; Progesterone

1980
In vitro hydrolysis of 19-norsteroid esters.
    Journal of steroid biochemistry, 1980, Volume: 13, Issue:4

    Topics: Adipose Tissue; Animals; Hydrolysis; In Vitro Techniques; Intestine, Small; Kidney; Liver; Lung; Lynestrenol; Muscles; Myocardium; Norethindrone; Norethindrone Acetate; Norgestrel; Norsteroids; Rabbits

1980
Endometrial pattern in long-term users of NET-EN.
    Journal of the Medical Association of Thailand = Chotmaihet thangphaet, 1993, Volume: 76, Issue:7

    Topics: Adult; Biopsy; Contraceptives, Oral, Synthetic; Endometrium; Female; Humans; Norethindrone

1993
Once-a-month injectable contraceptives.
    World health forum, 1993, Volume: 14, Issue:4

    Topics: Contraceptive Agents, Female; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone

1993
Cytokeratin 8, 18 and 19 in endometrial epithelium of Norplant and norethisterone enanthate injectable progestogen contraceptive users.
    Human reproduction (Oxford, England), 1996, Volume: 11 Suppl 2

    Topics: Adult; Animals; Antibodies, Monoclonal; Biopsy; Contraceptive Agents, Female; Endometrium; Female; Humans; Immunohistochemistry; Keratins; Levonorgestrel; Mice; Norethindrone

1996
Pharmacokinetics of orally administered norethisterone enanthate in rabbit, monkey, and women.
    Contraception, 1997, Volume: 55, Issue:6

    Topics: Administration, Oral; Animals; Contraceptives, Oral, Synthetic; Delayed-Action Preparations; Dose-Response Relationship, Drug; Female; Humans; Injections, Intramuscular; Macaca mulatta; Norethindrone; Rabbits; Time Factors

1997
Twelve years of injectable contraceptive use in a general practice.
    The British journal of family planning, 1998, Volume: 23, Issue:4

    Topics: Adolescent; Adult; Child; Contraceptive Agents, Female; Family Practice; Female; Humans; Injections, Subcutaneous; London; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Practice Patterns, Physicians'; Progesterone Congeners; Retrospective Studies

1998
Endometrial epithelial integrity and subepithelial reticular fibre expression in progestin contraceptive acceptors.
    Human reproduction (Oxford, England), 2000, Volume: 15 Suppl 3

    Topics: Adult; Biopsy; Collagen; Contraceptive Agents, Female; Endometrium; Epithelium; Female; Humans; Hysteroscopy; Immunohistochemistry; Keratins; Norethindrone; Progesterone Congeners; Silver Staining; Staining and Labeling; Uterine Hemorrhage

2000
Counting the costs: comparing depot medroxyprogesterone acetate and norethisterone oenanthate utilisation patterns in South Africa.
    BMC health services research, 2001, Volume: 1

    Topics: Adolescent; Adult; Age Factors; Choice Behavior; Contraceptive Agents, Female; Developing Countries; Drug Costs; Drugs, Essential; Female; Fertility; Health Expenditures; Health Services Needs and Demand; Humans; Injections; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Pharmacies; South Africa; Treatment Outcome

2001
Temporary discontinuation: a compliance issue in injectable users.
    Contraception, 2001, Volume: 64, Issue:5

    Topics: Adult; Cohort Studies; Contraception Behavior; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections; Medroxyprogesterone Acetate; Norethindrone; Patient Acceptance of Health Care; Patient Compliance

2001
Vaginal wetness: an underestimated problem experienced by progestogen injectable contraceptive users in South Africa.
    Social science & medicine (1982), 2002, Volume: 55, Issue:9

    Topics: Adolescent; Adult; Amenorrhea; Contraceptive Agents, Female; Cross-Sectional Studies; Family Characteristics; Female; Focus Groups; Health Knowledge, Attitudes, Practice; Humans; Injections, Intramuscular; Interviews as Topic; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Qualitative Research; Rural Population; Sexual Partners; South Africa; Vaginal Discharge

2002
Vaginal discharge: a perceived side effect and minor reason for discontinuation in hormonal injectable users in South Africa.
    African journal of reproductive health, 2001, Volume: 5, Issue:3

    Topics: Adult; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; Patient Compliance; South Africa; Vaginal Discharge

2001
Studies with 19-norethisterone oenanthate in mammary carcinoma.
    Proceedings of the Royal Society of Medicine, 1960, Volume: 53

    Topics: Breast; Breast Neoplasms; Humans; Norethindrone; Progesterone

1960
Detection of raised FSH levels among older women using depomedroxyprogesterone acetate and norethisterone enanthate.
    Contraception, 2003, Volume: 68, Issue:5

    Topics: Adult; Biomarkers; Case-Control Studies; Cohort Studies; Contraceptives, Oral, Combined; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone; Predictive Value of Tests

2003
Bone mineral density in women aged 40-49 years using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraceptives for contraception.
    Contraception, 2005, Volume: 71, Issue:3

    Topics: Adult; Body Mass Index; Bone Density; Cohort Studies; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Cross-Sectional Studies; Employment; Exercise; Female; Follicle Stimulating Hormone; Humans; Marital Status; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; South Africa; Time Factors

2005
Norethisterone enanthate has neither a direct effect on the testis nor on the epididymis: a study in adult male cynomolgus monkeys (Macaca fascicularis).
    European journal of endocrinology, 2005, Volume: 152, Issue:4

    Topics: Animals; Body Weight; Chorionic Gonadotropin; Contraceptive Agents, Male; Epididymis; Follicle Stimulating Hormone; Gonadotropin-Releasing Hormone; Macaca fascicularis; Male; Norethindrone; Sperm Count; Spermatids; Spermatogenesis; Testis; Testosterone

2005
Endogenous progesterone and the exogenous progestin norethisterone enanthate are associated with a proinflammatory profile in healthy men.
    The Journal of clinical endocrinology and metabolism, 2005, Volume: 90, Issue:12

    Topics: Adult; Androgens; Biomarkers; Contraceptive Agents, Male; Controlled Clinical Trials as Topic; Cross-Sectional Studies; Drug Synergism; Humans; Inflammation; Longitudinal Studies; Male; Middle Aged; Norethindrone; Progesterone; Progesterone Congeners; Testosterone; Testosterone Congeners

2005
Injectable contraceptives: a worldwide perspective.
    The journal of family planning and reproductive health care, 2002, Volume: 28, Issue:1

    Topics: Animals; Contraceptive Agents, Female; Developing Countries; Female; Global Health; Humans; Injections; Medroxyprogesterone Acetate; Models, Animal; Norethindrone

2002
Bleeding patterns of adolescents using a combination contraceptive injection for 1 year.
    Contraception, 2006, Volume: 73, Issue:6

    Topics: Adolescent; Adult; Contraceptive Agents, Female; Drug Combinations; Estradiol; Female; Humans; Injections, Intramuscular; Menstruation; Menstruation Disturbances; Norethindrone; Patient Compliance; Prospective Studies

2006
Preferences between injectable contraceptive methods among South African women.
    Contraception, 2006, Volume: 73, Issue:6

    Topics: Adolescent; Adult; Cross-Sectional Studies; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Patient Education as Topic; Patient Satisfaction; South Africa

2006
Bone mineral density in users of two kinds of once-a-month combined injectable contraceptives.
    Contraception, 2006, Volume: 74, Issue:3

    Topics: Absorptiometry, Photon; Adult; Body Mass Index; Bone Density; Contraceptive Agents, Female; Cross-Sectional Studies; Estradiol; Female; Humans; Injections; Medroxyprogesterone Acetate; Norethindrone; Radius; Ulna

2006
Bone mineral density in adolescents using norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives for contraception.
    Contraception, 2007, Volume: 75, Issue:6

    Topics: Absorptiometry, Photon; Adolescent; Adult; Bone Density; Contraceptives, Oral, Combined; Delayed-Action Preparations; Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone; Surveys and Questionnaires

2007
Injectable progestin contraceptive use and risk of HIV infection in a South African family planning cohort.
    Contraception, 2007, Volume: 75, Issue:6

    Topics: Adolescent; Adult; Cohort Studies; Contraceptive Agents, Female; Delayed-Action Preparations; Family Planning Services; Female; HIV Infections; Humans; Incidence; Medroxyprogesterone; Norethindrone; Prevalence; South Africa

2007
Bone status after cessation of use of injectable progestin contraceptives.
    Contraception, 2007, Volume: 76, Issue:6

    Topics: Adolescent; Adult; Ambulatory Care Facilities; Black People; Bone Density; Bone Resorption; Calcaneus; Contraceptive Agents, Female; Cross-Sectional Studies; Delayed-Action Preparations; Drug Administration Schedule; Female; Follow-Up Studies; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; South Africa; Ultrasonography

2007
Long-term effects of GnRH agonist, GnRH antagonist, and estrogen plus progesterone treatment on apoptosis related genes in rat ovary.
    Fertility and sterility, 2009, Volume: 91, Issue:5 Suppl

    Topics: Animals; Apoptosis; bcl-2-Associated X Protein; Estradiol; Estrogens; Female; Gonadotropin-Releasing Hormone; Leuprolide; Norethindrone; Ovary; Progesterone; Proto-Oncogene Proteins c-bcl-2; Rats; Rats, Wistar; Reverse Transcriptase Polymerase Chain Reaction

2009
Comparative performance of a combined injectable contraceptive (50 mg norethisterone enanthate plus 5mg estradiol valerate) and a combined oral contraceptive (0.15 mg levonorgestrel plus 0.03 mg ethinyl estradiol) in adolescents.
    Journal of pediatric and adolescent gynecology, 2009, Volume: 22, Issue:1

    Topics: Adolescent; Ambulatory Care Facilities; Contraceptives, Oral, Combined; Drug Administration Schedule; Drug Combinations; Estradiol; Ethinyl Estradiol; Female; Humans; Injections, Intramuscular; Levonorgestrel; Medication Adherence; Norethindrone; Patient Satisfaction; Prospective Studies; Young Adult

2009
Bone mineral density in a cohort of adolescents during use of norethisterone enanthate, depot-medroxyprogesterone acetate or combined oral contraceptives and after discontinuation of norethisterone enanthate.
    Contraception, 2009, Volume: 79, Issue:5

    Topics: Adolescent; Bone Density; Contraceptives, Oral, Combined; Delayed-Action Preparations; Female; Humans; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Young Adult

2009
Bone mineral density in young women aged 19-24 after 4-5 years of exclusive and mixed use of hormonal contraception.
    Contraception, 2009, Volume: 80, Issue:2

    Topics: Bone Diseases, Metabolic; Case-Control Studies; Contraceptives, Oral, Combined; Cross-Sectional Studies; Female; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Norethindrone; Time; Young Adult

2009
Use of injectable progestin contraception and risk of STI among South African women.
    Contraception, 2009, Volume: 80, Issue:6

    Topics: Adolescent; Adult; Condoms; Female; Humans; Medroxyprogesterone Acetate; Multivariate Analysis; Norethindrone; Patient Selection; Pregnancy; Regression Analysis; Risk Factors; Sexually Transmitted Diseases, Bacterial; South Africa; Vaginitis

2009
Prospective study of weight change in new adolescent users of DMPA, NET-EN, COCs, nonusers and discontinuers of hormonal contraception.
    Contraception, 2010, Volume: 81, Issue:1

    Topics: Adolescent; Body Mass Index; Body Weight; Contraception Behavior; Contraceptives, Oral, Combined; Female; Humans; Longitudinal Studies; Medroxyprogesterone Acetate; Norethindrone; Prospective Studies; Weight Gain; Withholding Treatment; Young Adult

2010
Clinical experience with injectable progestogen- only contraceptives at University of Ilorin teaching hospital: a five year review.
    The Nigerian postgraduate medical journal, 2009, Volume: 16, Issue:4

    Topics: Adult; Age Distribution; Contraceptive Agents, Female; Contraceptives, Oral, Synthetic; Educational Status; Female; Hospitals, Teaching; Humans; Injections, Intramuscular; Medroxyprogesterone Acetate; Menstruation Disturbances; Middle Aged; Nigeria; Norethindrone; Retrospective Studies; Risk Factors; Universities

2009
Contraceptive options for women in selected circumstances.
    Best practice & research. Clinical obstetrics & gynaecology, 2010, Volume: 24, Issue:5

    Topics: Adolescent; Adult; Anemia; Breast Diseases; Cardiovascular Diseases; Condoms; Contraception; Contraceptive Agents, Female; Contraindications; Desogestrel; Diabetes Mellitus; Drug Combinations; Drug Implants; Epilepsy; Ethinyl Estradiol; Female; Heart Valve Diseases; Humans; Hypertension; Inflammatory Bowel Diseases; Injections; Intrauterine Devices; Levonorgestrel; Liver Diseases; Lupus Erythematosus, Systemic; Medroxyprogesterone Acetate; Migraine Disorders; Norethindrone; Norgestrel; Obesity; Patient Preference; Pregnancy; Progestins; Stroke; Young Adult

2010
Assessing menopausal status in women aged 40 - 49 using depot-medroxyprogesterone acetate, norethisterone enanthate or combined oral contraception.
    South African medical journal = Suid-Afrikaanse tydskrif vir geneeskunde, 2011, Volume: 101, Issue:2

    Topics: Adult; Contraceptive Agents, Female; Contraceptives, Oral, Combined; Female; Follicle Stimulating Hormone; Humans; Medroxyprogesterone Acetate; Menopause; Middle Aged; Norethindrone

2011
Testosterone-induced prostate growth is blocked by co- and preadministration of norethisterone enanthate in castrated cynomolgus monkeys.
    Urologia internationalis, 2012, Volume: 88, Issue:3

    Topics: Animals; Biomarkers; Body Weight; Drug Administration Schedule; Hematocrit; Hormone Replacement Therapy; Macaca fascicularis; Male; Norethindrone; Orchiectomy; Organ Size; Progestins; Prostate; Testosterone; Time Factors

2012
Experimental endocrine manipulation by contraceptive regimen in the male marmoset (Callithrix jacchus).
    Reproduction (Cambridge, England), 2013, Volume: 145, Issue:4

    Topics: Animals; Antispermatogenic Agents; Body Weight; Callithrix; Chorionic Gonadotropin; Epididymis; Fertility; Male; Models, Animal; Norethindrone; Organ Size; Pituitary Gland; Ploidies; Sperm Motility; Testis; Testosterone

2013
Next steps for research on hormonal contraception and HIV.
    Lancet (London, England), 2013, Nov-02, Volume: 382, Issue:9903

    Topics: Contraception; Contraceptive Agents, Female; Female; HIV Infections; Humans; Medroxyprogesterone Acetate; Norethindrone; Randomized Controlled Trials as Topic; Risk Assessment

2013
The effectiveness of community based distribution of injectable contraceptives using community health extension workers in Gombe State, Northern Nigeria.
    African journal of reproductive health, 2013, Volume: 17, Issue:2

    Topics: Adolescent; Adult; Community Health Workers; Condoms; Condoms, Female; Contraceptive Agents, Female; Delivery of Health Care; Feasibility Studies; Female; Health Promotion; Humans; Injections; Male; Maternal Mortality; Medroxyprogesterone Acetate; Middle Aged; Nigeria; Norethindrone; Socioeconomic Factors

2013
Highlights from the 21st CROI.
    The Lancet. Infectious diseases, 2014, Volume: 14, Issue:4

    Topics: Animals; Anti-HIV Agents; Child; Contraceptive Agents, Female; Delayed-Action Preparations; Female; Hepatitis C; HIV Infections; Humans; Infant, Newborn; Male; Medication Adherence; Medroxyprogesterone Acetate; Norethindrone

2014
Clinicians' perceptions and provision of hormonal contraceptives for HIV-positive and at-risk women in Southern Africa: an original research article.
    Contraception, 2014, Volume: 90, Issue:4

    Topics: Adult; Aged; Attitude of Health Personnel; Contraceptives, Oral; Contraceptives, Postcoital, Hormonal; Directive Counseling; Evidence-Based Medicine; Family Planning Services; Female; Health Care Surveys; HIV Seropositivity; Humans; Injections, Intramuscular; Male; Medroxyprogesterone Acetate; Middle Aged; Norethindrone; Practice Patterns, Nurses'; Practice Patterns, Physicians'; Risk Factors; South Africa; Young Adult; Zimbabwe

2014
Injectable Progestin-Only Contraception is Associated With Increased Levels of Pro-Inflammatory Cytokines in the Female Genital Tract.
    American journal of reproductive immunology (New York, N.Y. : 1989), 2015, Volume: 74, Issue:4

    Topics: Adolescent; Adult; Contraception; Contraceptive Agents, Female; Cross-Sectional Studies; Cytokines; Female; Genitalia, Female; HIV Infections; Humans; Inflammation; Kenya; Medroxyprogesterone Acetate; Norethindrone; Pregnancy; Progestins; Sexually Transmitted Diseases, Bacterial; South Africa; Vaginosis, Bacterial; Young Adult

2015
Norethisterone enanthate-induced cerebral venous sinus thrombosis (CVST).
    BMJ case reports, 2017, Nov-14, Volume: 2017

    Topics: Anticoagulants; Contraceptive Agents, Female; Female; Headache; Heparin; Humans; Injections, Intramuscular; Magnetic Resonance Imaging; Norethindrone; Parietal Lobe; Sinus Thrombosis, Intracranial; Young Adult

2017
Impact of contraceptive initiation on vaginal microbiota.
    American journal of obstetrics and gynecology, 2018, Volume: 218, Issue:6

    Topics: Adult; Contraceptive Agents, Female; Desogestrel; DNA, Bacterial; Drug Implants; Ethinyl Estradiol; Female; Gardnerella vaginalis; Humans; Intrauterine Devices, Copper; Lactobacillus crispatus; Lactobacillus gasseri; Levonorgestrel; Medroxyprogesterone Acetate; Megasphaera; Microbiota; Norethindrone; Polymerase Chain Reaction; Protective Factors; Risk Factors; Vagina; Vaginosis, Bacterial; Young Adult

2018
Depot medroxyprogesterone acetate and norethisterone enanthate differentially impact T-cell responses and expression of immunosuppressive markers.
    American journal of reproductive immunology (New York, N.Y. : 1989), 2020, Volume: 83, Issue:3

    Topics: Adolescent; Adult; CD4-Positive T-Lymphocytes; CD8-Positive T-Lymphocytes; Cells, Cultured; Contraceptive Agents, Female; CTLA-4 Antigen; Female; Humans; Immunophenotyping; Lymphocyte Activation; Medroxyprogesterone Acetate; Norethindrone; Programmed Cell Death 1 Receptor; Young Adult

2020
Norethisterone Enanthate Increases Mouse Susceptibility to Genital Infection with Herpes Simplex Virus Type 2 and HIV Type 1.
    ImmunoHorizons, 2020, 02-11, Volume: 4, Issue:2

    Topics: Animals; Contraceptive Agents, Female; Desmoglein 1; Disease Susceptibility; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Medroxyprogesterone Acetate; Mice; Mice, Inbred C57BL; Mice, SCID; Mucous Membrane; Norethindrone; Permeability; Vagina

2020